Clinical Trial Update: HIV-1 Peptide Immunisation of Individuals in West Africa to Prevent Disease [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating an HIV-1 peptide vaccine to prevent HIV infection in West Africa; the study is completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• HIV-1 peptide vaccine

Snippet

Sponsor: Statens Serum Institut | Conditions: Aids, Cdc Group I | Phase 1 | Status: COMPLETED | Results posted: 2012-10-15